Haian Fu, PhD, was named Chair of the Department of Pharmacology, effective September 1, 2017. Dr. Fu joined the School of Medicine in 1994, and is currently serving as Professor of Pharmacology and Associate Dean for Innovation and International Strategies. He holds additional roles at Winship Cancer Institute, serving as a Professor of Hematology and Medical Oncology, a Winship Partner in Research Endowed Chair, and Leader of the Discovery and Developmental Therapeutics Program. Fu has effectively been serving as co-chair of the Department of Pharmacology since March, along with Ray Dingledine, PhD. Fu will build upon an outstanding Pharmacology Department. Dr. Dingledine has held the role of Chair for 25 years since joining Emory in 1992 with a simple but compelling vision of bringing cellular and molecular biological approaches to department research programs. He will continue this research in the department.
Dr. Fu’s research interests include cancer biology and chemical biology, with a focus on targeting protein-protein interaction networks in cell signaling for therapeutic agent discovery and translational research. He actively collaborates with physician scientists, chemists and disease biologists to advance research to benefit patients, contributes to national initiatives by serving on the NCI Cancer Target Discovery & Development (CTD2) Network steering committee and the NCI Chemical Biology Consortium steering committee, and leads a global effort in promoting chemical biology. Fu is a co-founder, past president and current chair of the Board of Directors for the International Chemical Biology Society. Fu is a recognized as a collaborative research leader with more than $30 million federal funding as a PI or co-PI in the past two decades.